Siefker-Radtke, A. O.; Mellado, B.; Decaestecker, K.; Burke, J. M.; O'Hagan, A.; Avadhani, A.; Zhong, B.; Santiago-Walker, A.; De Porre, P.; Brookman-May, S. and Garcia-Donas, J.
(2016):
Ongoing phase 2 study of erdafitinib (JNJ-42756493), a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients (pts) with metastatic or unresectable urothelial carcinoma (M/UR UC) and FGFR gene alterations.
In: Annals of Oncology, Vol. 27
Item Type: | Journal article |
---|---|
Faculties: | Medicine |
Subjects: | 600 Technology > 610 Medicine and health |
ISSN: | 0923-7534 |
Language: | English |
Item ID: | 46063 |
Date Deposited: | 27. Apr 2018, 08:10 |
Last Modified: | 04. Nov 2020, 13:22 |